FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Aurobindo Pharma Limited, authorizing a generic Levetiracetam product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Idiopathic Generalized Epilepsy
• Juvenile Myoclonic Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)